Clinical Trial Update: Indigotindisulfonate Sodium Injection, USP as an Aid in the Determination of Ureteral Patency in Pediatric Patients [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update for Indigotindisulfonate Sodium Injection, USP to aid in determining ureter patency in pediatric patients; the study status is N…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ureteral Injury

Drugs mentioned

• Indigotindisulfonate Sodium Injection, USP (indigotindisulfonate sodium)

Snippet

Sponsor: Prove pharm | Conditions: Ureter Injury | Phase 3 | Status: NOT_YET_RECRUITING